CATIE news story
To better understand changes in the immune systems of ART users, a team of scientists at the University of Calgary and the Southern Alberta HIV Clinic conducted a study. The team focused on the CD4/CD8 ratio in people with HIV who had a suppressed viral load due to ART. The researchers were interested in finding factors that could help explain why some people’s CD4/CD8 ratios do not normalize despite prolonged use of ART.
The researchers analyzed health-related information collected from 2,179 people with HIV between January 1998 and June 2022 — a span of 24 years. On average, participants were in the study for a decade. According to the research team, most participants were cisgender males and White and disclosed that they were either gay/bisexual or heterosexual. The proportion of people who injected drugs was relatively low. At the time they entered the study, participants had an average CD4+ count of 257 cells/mm3 and their average age was 35 years.
Read the full news story here.
Source : CATIE
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.